ANXA3 hypomethylation as a prognostic biomarker in hepatitis B virus-related acute-on-chronic liver failure
ANXA3 hypomethylation has a prominent predictive value for short-term mortality in patients with HBV-ACLF and may serve as a promising biomarker of HBV-ACLF prognosis.
Authors
- Yu‐Chen Fan (ORCID: https://orcid.org/0000-0002-9126-679X)
- Hanxu Zhu
- Chao Cui (ORCID: https://orcid.org/0000-0002-7868-6263)
- Hui Lv
- Xue-Fei Wei
- Huihui Liu (ORCID: https://orcid.org/0000-0001-5331-8264)
- Jingwei Wang (ORCID: https://orcid.org/0000-0001-5988-1496)
- Zhaohui Wang (ORCID: https://orcid.org/0000-0002-3253-7078)
- Ying Zhang (ORCID: https://orcid.org/0000-0003-2194-7116)
- Kai You Wang (ORCID: https://orcid.org/0000-0002-6170-4744)
- Na Wang (ORCID: https://orcid.org/0000-0002-4578-4609)
- Pengyu Luo
Institutions
- Shandong University (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-12-07
- DOI
- https://doi.org/10.1080/07853890.2025.2595332
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00